
Company valuation, historical trends, and peer comparisons.
According to Precision BioSciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 131.92M. This represents a change of 105.67% compared to the average of 64.14M of the last 4 quarters.
The mean historical Enterprise Value of Precision BioSciences, Inc. over the last ten years is 1.08B. The current 131.92M Enterprise Value has changed -87.82% with respect to the historical average. Over the past ten years (40 quarters), DTIL's Enterprise Value was at its highest in in the March 2019 quarter at 775.57M. The Enterprise Value was at its lowest in in the September 2023 quarter at -59059022.08.
Average
1.08B
Median
327.20M
Minimum
-60016820.70
Maximum
8.66B
Discovering the peaks and valleys of Precision BioSciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 43.46%
Maximum Annual Enterprise Value = 8.66B
Minimum Annual Increase = -120.02%
Minimum Annual Enterprise Value = -60016820.70
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | -28658515.52 | -3.90% |
| 2024 | -29820338.58 | -31.20% |
| 2023 | -43346615.25 | -27.78% |
| 2022 | -60016820.70 | -120.02% |
| 2021 | 299.74M | -15.49% |
| 2020 | 354.67M | -11.88% |
| 2019 | 402.49M | -46.47% |
| 2018 | 751.89M | 43.46% |
| 2017 | 524.12M | -93.95% |
The current Enterprise Value of Precision BioSciences, Inc. (DTIL) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-33941823.12
5-year avg
27.58M
10-year avg
1.08B
Precision BioSciences, Inc.’s Enterprise Value is greater than Acumen Pharmaceuticals, Inc. (-8518659.00), less than Alector, Inc. (209.00M), greater than Gossamer Bio, Inc. (56.07M), greater than HOOKIPA Pharma Inc. (-22891217.00), less than Heron Therapeutics, Inc. (182.63M), greater than Kaleido Biosciences, Inc. (-16775738.00), less than Q32 Bio Inc. (154.45M), greater than Atrium Therapeutics, Inc. (74.26M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -8518659.00 | $18.28M | |
| 209.00M | $236.15M | |
| 56.07M | $58.11M | |
| -22891217.00 | $14.40M | |
| 182.63M | $55.00M | |
| -16775738.00 | $4.26K | |
| 154.45M | $255.42M | |
| 74.26M | $145.23M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Precision BioSciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Precision BioSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Precision BioSciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Precision BioSciences, Inc. (DTIL)?
What is the 3-year average Enterprise Value for Precision BioSciences, Inc. (DTIL)?
What is the 5-year average Enterprise Value for Precision BioSciences, Inc. (DTIL)?
How does the current Enterprise Value for Precision BioSciences, Inc. (DTIL) compare to its historical average?